Crinetics Pharmaceuticals (CRNX) Depreciation & Amortization (CF) (2017 - 2026)
Crinetics Pharmaceuticals' quarterly Depreciation & Amortization (CF) came in at $1.2 million in Q1 2026, up 25.41% year-on-year from $925000.0 in Q1 2025, and up 16.7% quarter-over-quarter from $994000.0 in Q4 2025.
Crinetics Pharmaceuticals has reported Depreciation & Amortization (CF) for 10 years, with the latest figure at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 25.41% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.1 million (up 27.47% YoY), and the FY2025 full-year result was $3.9 million, up 39.68% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $1.2 million, up from $994000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $1.2 million in Q1 2026, with the low at $215000.0 in Q2 2022.
- Average Depreciation & Amortization (CF) over 5 years is $583294.1, with a median of $474000.0 recorded in 2024.
- Year-over-year, Depreciation & Amortization (CF) slipped 6.52% in 2022 and surged 200.76% in 2024.
- Tracing CRNX's Depreciation & Amortization (CF) over 5 years: stood at $280000.0 in 2022, then dropped by 6.43% to $262000.0 in 2023, then surged by 200.76% to $788000.0 in 2024, then climbed by 26.14% to $994000.0 in 2025, then increased by 16.7% to $1.2 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $1.2 million (Q1 2026), $994000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16 Mn |
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 994,000.00 |
| Dec 31, 2025 | 994,000.00 |
| Sep 30, 2025 | 1.01 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 959,000.00 |
| Jun 30, 2025 | 959,000.00 |
| Mar 31, 2025 | 925,000.00 |
| Mar 31, 2025 | 925,000.00 |
| Dec 31, 2024 | 788,000.00 |
| Dec 31, 2024 | 788,000.00 |
| Sep 30, 2024 | 770,000.00 |
| Sep 30, 2024 | 770,000.00 |
| Jun 30, 2024 | 753,000.00 |
| Jun 30, 2024 | 753,000.00 |
| Mar 31, 2024 | 474,000.00 |
| Mar 31, 2024 | 474,000.00 |
| Dec 31, 2023 | 262,000.00 |
| Dec 31, 2023 | 262,000.00 |
| Sep 30, 2023 | 273,000.00 |
| Sep 30, 2023 | 273,000.00 |
| Jun 30, 2023 | 280,000.00 |
| Jun 30, 2023 | 280,000.00 |
| Mar 31, 2023 | 283,000.00 |
| Mar 31, 2023 | 283,000.00 |
| Dec 31, 2022 | 280,000.00 |
| Dec 31, 2022 | 280,000.00 |
| Sep 30, 2022 | 248,000.00 |
| Sep 30, 2022 | 248,000.00 |
| Jun 30, 2022 | 215,000.00 |
| Jun 30, 2022 | 215,000.00 |
| Mar 31, 2022 | 240,000.00 |
| Mar 31, 2022 | 240,000.00 |
| Dec 31, 2021 | 235,000.00 |
| Dec 31, 2021 | 235,000.00 |
| Sep 30, 2021 | 233,000.00 |
| Sep 30, 2021 | 233,000.00 |
| Jun 30, 2021 | 230,000.00 |
| Jun 30, 2021 | 230,000.00 |
| Mar 31, 2021 | 224,000.00 |
| Mar 31, 2021 | 224,000.00 |
| Dec 31, 2020 | 225,000.00 |
| Dec 31, 2020 | 225,000.00 |
| Sep 30, 2020 | 244,000.00 |
| Sep 30, 2020 | 244,000.00 |
| Jun 30, 2020 | 244,000.00 |
| Jun 30, 2020 | 244,000.00 |
| Mar 31, 2020 | 235,000.00 |
| Mar 31, 2020 | 235,000.00 |
| Dec 31, 2019 | 229,000.00 |
| Dec 31, 2019 | 229,000.00 |
| Sep 30, 2019 | 228,000.00 |
| Sep 30, 2019 | 228,000.00 |
| Jun 30, 2019 | 230,000.00 |
| Jun 30, 2019 | 230,000.00 |
| Mar 31, 2019 | 200,000.00 |
| Mar 31, 2019 | 200,000.00 |
| Dec 31, 2018 | 208,000.00 |
| Dec 31, 2018 | 208,000.00 |
| Sep 30, 2018 | 139,000.00 |
| Sep 30, 2018 | 139,000.00 |
| Jun 30, 2018 | 76,000.00 |
| Jun 30, 2018 | 76,000.00 |
| Mar 31, 2018 | 48,000.00 |
| Mar 31, 2018 | 48,000.00 |
| Dec 31, 2017 | 48,000.00 |
| Dec 31, 2017 | 48,000.00 |
| Sep 30, 2017 | 28,000.00 |
| Sep 30, 2017 | 28,000.00 |